The DEEP Trial results demonstrate improved quality of life in patients with persistent and long-standing persistent Afib who underwent hybrid ablation and LAA exclusion with an AtriClip® device.
Read the data here: <a href="https://okt.to/Bpkzm0" target="_blank">https://okt.to/Bpkzm0</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>
